ReviewCost effectiveness and resource allocation : C/E2025

Fair pricing, fair access; a systematic review of cost-effectiveness of new hyperlipidemia injectable medication in developing countries.

Samad Azari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.